Ashley NG

Doctor
Medicine
Peter MacCallum Cancer Centre
Australia

Doctor Haematology
Biography

Dr Ashley Ng is a clinical haematologist with expertise in treating a range of benign and malignant haematological conditions and bone marrow transplant. His specific clinical interest at the VCCC is in the treatment of acute leukemia. He graduated first in class with honours for his medical degree (MBBS), and completing a Bachelor of Medical Science (BMedSci) during his undergraduate training. He undertook haematology training while conducting clinical research projects in the areas of thrombosis, infectious diseases, lymphoma, positron-emission tomography scanning and haemato-pathology, and participating in the design of the Australia Lymphoma and Leukemia Group Non-Hodgkin Lymphoma NHL21 clinical trial. Following completion of dual fellowships in haematology (FRACP) and haemato-pathology (FRCPA Haem), he trained in molecular and cellular biology undertaking a PhD with Professor Warren Alexander and Associate Professor Benjamin Kile at WEHI (2007-2010), elucidating the role of the transcription factor Erg in haematopoietic stem cell function.

Research Intrest

CLINICAL HAEMATOLOGY AND BONE MARROW TRANSPLANT

List of Publications
Ng AP, Kauppi M, Metcalf D, Hyland CD, Josefsson EC, Lebois M, et al. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation. Proc Natl Acad Sci USA. 2014 Apr 22;111(16):5884–9.
Ng AP, Hu Y, Metcalf D, Hyland CD, Ierino H, Phipson B, et al. Early Lineage Priming by Trisomy of Erg Leads to Myeloproliferation in a Down Syndrome Model. 2015;11(5):e1005211.
Ng AP, Hyland CD, Metcalf D, Carmichael CL, Loughran SJ, Di Rago L, et al. Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome. Blood. American Society of Hematology; 2010 May 13;115(19):3966–9.